GlassScriptPhysician profile
Jon Edgington
NPI 1992185292
$25,562.08
in general payments reported to CMS, 2019-2025
21 companies · $341 in 2025
The $341 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,040 · 2020: $11K · 2021: $11K · 2022: $1,784 · 2023: $490 · 2024: $634 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,034 · Travel and Lodging: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,033.92 |
| Travel and Lodging | $430.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $21,400.25 | 2020-2024 | Real Intelligence, Journey II, Ri Hip Navigation |
| Stryker Corporation | $1,634.36 | 2019-2025 | Mako, Triathlon, T2 Alpha |
| Medical Device Business Services, INC. | $837.44 | 2019-2020 | |
| Medacta USA, INC. | $807.21 | 2020-2024 | |
| Depuy Synthes Sales INC. | $283.33 | 2019-2025 | Na, Monovisc, Orthovisc |
| Pacira Pharmaceuticals Incorporated | $81.82 | 2021-2023 | Iovera, Zilretta |
| Ethicon US, LLC | $78.34 | 2021-2025 | Ethicon, Dermabond Prineo, Stratafix |
| Novo Nordisk INC | $69.02 | 2022 | |
| Ferring Pharmaceuticals INC. | $66.30 | 2022-2025 | Euflexxa |
| Davol INC. | $43.47 | 2025 | Arista |
| Lightbody Medical Technologies INC | $38.52 | 2025 | |
| Convatec INC. | $34.92 | 2022-2023 | |
| Pacira Therapeutics, INC. | $32.79 | 2021 | |
| Zimmer Biomet Holdings, INC. | $31.82 | 2025 | Arcos |
| Microport Orthopedics INC | $23.19 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $21.76 | 2022 | |
| Heron Therapeutics, INC. | $21.04 | 2024 | Zynrelef |
| Orthofix Medical, INC. | $14.96 | 2021 | |
| Kerecis Limited | $14.68 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Heraeus Medical, LLC. | $14.63 | 2021 | |
| Medwest Associates | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Edgington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.